334 related articles for article (PubMed ID: 28530524)
21. Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs.
Yeung K; Suh K; Basu A; Garrison LP; Bansal A; Carlson JJ
J Manag Care Spec Pharm; 2017 Oct; 23(10):1084-1090. PubMed ID: 28944726
[TBL] [Abstract][Full Text] [Related]
22. Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage Policies.
Chambers JD; Pope EF; Wilkinson CL; Neumann PJ
J Manag Care Spec Pharm; 2018 Dec; 24(12):1240-1246. PubMed ID: 30479201
[TBL] [Abstract][Full Text] [Related]
23. AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.
J Manag Care Spec Pharm; 2016 Jul; 22(7):826-31. PubMed ID: 27333323
[TBL] [Abstract][Full Text] [Related]
24. AMCP Partnership Forum: Optimizing Prior Authorization for Appropriate Medication Selection.
J Manag Care Spec Pharm; 2020 Jan; 26(1):55-62. PubMed ID: 31880226
[TBL] [Abstract][Full Text] [Related]
25. Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment.
Timbie JW; Kim AY; Concannon TW
Value Health; 2021 Dec; 24(12):1792-1798. PubMed ID: 34838277
[TBL] [Abstract][Full Text] [Related]
26. Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia.
Shafrin J; Schwartz TT; Lakdawalla DN; Forma FM
J Manag Care Spec Pharm; 2016 Nov; 22(11):1285-1291. PubMed ID: 27783545
[TBL] [Abstract][Full Text] [Related]
27. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
28. Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review.
Lasky T; Carleton B; Horton DB; Kelly LE; Bennett D; Czaja AS; Gifkins D; Osokogu OU; McMahon AW
Drugs Real World Outcomes; 2020 Jun; 7(2):97-107. PubMed ID: 32112359
[TBL] [Abstract][Full Text] [Related]
29. Validating a Budget Impact Model Using Payer Insight and Claims Data: A Framework and Case Study.
Hung A; Slejko JF; Lugo A; Shaya F; Haines ST; Mullins CD
J Manag Care Spec Pharm; 2019 Aug; 25(8):913-921. PubMed ID: 31347981
[TBL] [Abstract][Full Text] [Related]
30. Variation in health plan coverage of ESAs for anemia due to chronic kidney disease.
Margaretos NM; Panzer AD; Lai RC; Sanon M; Michalopoulos E; Redmond AM; Moghadam R; Chambers JD
J Manag Care Spec Pharm; 2021 Sep; 27(9):1221-1229. PubMed ID: 34464213
[No Abstract] [Full Text] [Related]
31. Evaluating the Training, Responsibilities, and Practices of P&T Committee Members and Nonmember Contributors.
Rodriguez R; Kelly BJ; Moody M
J Manag Care Spec Pharm; 2017 Aug; 23(8):868-874. PubMed ID: 28737984
[TBL] [Abstract][Full Text] [Related]
32. A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions.
Pearson SD; Dreitlein WB; Towse A; Hampson G; Henshall C
J Comp Eff Res; 2018 Dec; 7(12):1145-1152. PubMed ID: 30427724
[TBL] [Abstract][Full Text] [Related]
33. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
[TBL] [Abstract][Full Text] [Related]
34. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
35. Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: results of a small survey of managed care organizations and pharmaceutical manufacturers.
Nichol MB; Knight TK; Epstein J; Honda DH; Tretiak R
J Manag Care Pharm; 2007 May; 13(4):360-71. PubMed ID: 17506602
[TBL] [Abstract][Full Text] [Related]
36. Advancing a managed care pharmacy research agenda: Generating real-world evidence to support US Food and Drug Administration Accelerated Approvals and improving benefit design to address health inequities.
Brixner D; Couto J; Worley K; Small A; Panchal R; Dharbhamalla V; Eichenbrenner P
J Manag Care Spec Pharm; 2022 Aug; 28(8):911-917. PubMed ID: 35722828
[TBL] [Abstract][Full Text] [Related]
37. Contemporary Databases in Real-world Studies Regarding the Diverse Health Care Systems of India, Thailand, and Taiwan: Protocol for a Scoping Review.
Shau WY; Setia S; Shinde SP; Santoso H; Furtner D
JMIR Res Protoc; 2022 Dec; 11(12):e43741. PubMed ID: 36512386
[TBL] [Abstract][Full Text] [Related]
38. Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research.
Happe LE; Brown JD; Gatwood J; Schneeweiss S; Wang S
J Manag Care Spec Pharm; 2020 Mar; 26(3):268-274. PubMed ID: 32105168
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
40. EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS.
Chambers JD; Saret CJ; Anderson JE; Deverka PA; Douglas MP; Phillips KA
Int J Technol Assess Health Care; 2017 Jan; 33(4):534-540. PubMed ID: 29065945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
